Intage holdings reports soaring Q1 operating profit despite sales dip

Intage Holdings Inc. announced its consolidated financial results for the three months ended September 30, 2025, revealing a substantial rise in profitability. Net sales for the period were 14,361 million yen, a 4.6% decrease from the previous year, primarily due to the transfer of the CRO business and a rebound effect from large-scale projects. However, operating profit surged by 205.6% to 572 million yen, and ordinary profit increased by 429.2% to 565 million yen. This was driven by reduced costs, lower personnel expenses, and decreased investment following the completion of the new SCI transition. Profit attributable to owners of parent declined by 74.2% to 292 million yen due to the absence of gains from the CRO business transfer in the prior period.

The Marketing Support (Consumer Goods & Services) segment saw net sales of 10,041 million yen, a slight decrease of 0.2%, but operating loss narrowed significantly to 40 million yen. This improvement was attributed to strong panel surveys and custom research, as well as reduced investment. The Marketing Support (Healthcare) segment’s net sales decreased by 14.4% to 2,727 million yen, but operating profit soared by 81.1% to 507 million yen, benefiting from price increases and the expansion of the prescription database. Conversely, the Business Intelligence segment experienced a decline, with net sales down 11.9% to 1,592 million yen and operating profit falling 46.4% to 105 million yen.

The company's financial position at September 30, 2025, showed total assets of 44,673,322 thousand yen, down from 46,922,658 thousand yen at June 30, 2025. Current assets decreased mainly due to a fall in cash and deposits. The forecast for the fiscal year ending June 30, 2026, projects net sales of 70,000 million yen, operating profit of 5,600 million yen, and ordinary profit of 5,500 million yen, with profit attributable to owners of parent expected to be 3,200 million yen.